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Purpose: Epithelial disorders after eye surgery can result in visual deterioration and patient 
discomfort. Such disorders may be caused by drug toxicity. In the present study, we evaluated 
the toxicity of ophthalmic solutions, with or without benzalkonium chloride (BAK) as the 
preservative, used for postoperative care.
Methods: A range of commercially available antibiotic and anti-inflammatory ophthalmic 
solutions used postoperatively (ie, levofloxacin, moxifloxacin, gatifloxacin, norfloxacin, tosu-
floxacin, dibekacin, cefmenoxime, diclofenac, bromfenac, pranoprofen, betamethasone, and 
fluoromethorone) were assessed in three corneal cell lines and one conjunctival cell line. All 
antibiotic solutions were BAK free. Cell viability was determined with the 3-(4,5-dimethyl-2 
thiazoyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay after cells had been exposed to 
the drugs for 48 h. The effects of preservatives on cell viability were also determined. Toxicity 
was compared using the cell viability score (CVS).
Results: Based on results of the MTT assay and CVS, the order of cell viability after exposure 
to the antibiotic solutions was cefmenoxime $ tosufloxicin $ dibekacin $ levofloxacin $ 
norfloxacin = gatifloxacin = moxifloxacin. For the anti-inflammatory solutions, the order of cell 
viability was betamethasone $ betamethasone + fradiomycin . preservative-free diclofenac $ 
preservative-free bromfenac .. 0.02% fluoromethorone $ 0.1% fluoromethorone = diclofenac + 
preservative = bromfenac + preservative = pranoprofen. The anti-inflammatory drugs were more 
toxic than the antibiotics. The toxicity of antibiotic drugs against ocular surface cells was depen-
dent on the pharmaceutical components of the solution, whereas that of the anti-  inflammatory 
drugs was dependent on both the pharmaceutical components and the preservatives.
Conclusion: Postoperative drug-induced epitheliopathy may be caused primarily by 
  anti-inflammatory drugs. CVS is useful in comparing the cytotoxicity of different drugs.
Keywords: toxicity, preservative, cornea, eye
Introduction
Common preservatives used in ophthalmic solutions include benzalkonium chloride 
(BAK), chlorobutanol, methyl paraoxybenzoate, propyl paraoxybenzoate, and boric 
acid. The toxicity of these preservatives against ocular surface cells, namely the cornea 
and conjunctiva, has been investigated extensively1–10 because epithelial disorders are 
of particular concern postoperatively, as well as in patients using eye drops over the 
longer term, and those with dry eye. In the present study, we examined the toxicity 
of ophthalmic solutions commonly used after eye surgery to control infection and 
inflammation in a bioassay using four established ocular surface cell lines. A further Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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aim of the present study was to develop a scoring method 
of cell viability to enable the easy comparison of drugs, 
because many toxicity studies use multiple methods to evalu-
ate cell damage and data evaluation consequently becomes 
complicated.
Material and methods
The commercially available cell lines used in the present 
study were the SIRC (rabbit corneal epithelium; ATCC 
CCL-60; American Type Culture Collection (ATCC), Manas-
sas, VA, USA), BCE C/D-1b (bovine corneal epithelial 
cells; JCRB-9129; Health Science Research Resource Bank, 
Osaka, Japan), RC-1 (rabbit corneal epithelium; JCRB-0246; 
Health Science Research Resource Bank) and Chang con-
junctiva (human conjunctival cells; ATCC CCL-20.2; ATCC) 
lines. All cells were cultured according to standard protocols 
provided by the distributors.
After cells had reached 80%−90% confluence and had 
been cultured under standard conditions for 48 h, a 100µL 
aliquot of the culture containing approximately 2 × 104 cells 
was harvested from the culture wells. The different drugs 
and preservatives to be tested were diluted 10-, 20-, 100-, 
1,000-, and, when necessary, 10,000-fold with phosphate 
buffered saline before being added to the cells in culture. Cell 
viability was determined after 48 h incubation in the presence 
of the test solutions using the 3-(4,5-dimethyl-2 thiazoyl)-
  2,5-diphenyl-2H-tetrazolium bromide (MTT) assay (Sigma, 
St Louis, MO, USA), a quantitative   colorimetric measure 
of mitochondrial activity as an index of cell viability and 
proliferation. Absorbance was read on a spectrophotometer 
(Benchmark Microplate Reader; Bio-Rad, Hercules, CA, 
USA). The MTT assay detects living cells only and the   signal 
generated is directly proportional to the number of live cells. 
The   viability of cells in test solutions was calculated as a 
percentage of cells incubated in growth medium without 
test solution.   Experiments were repeated between eight and 
16 times and the results are given as the mean ± standard 
deviation (SD).
Because the results of preliminary experiments indi-
cated that viability increased markedly in solutions that had 
been diluted 20-fold or more and the differences among 
the drugs were evident enough in 10-fold diluted solutions, 
we expressed the results as a cell viability score (CVS50), 
a number of cell lines with viability $50% in the presence 
of a 10-fold dilution of the drug, to enable easy comparison 
of the effects of different drugs. This concept is similar to the 
MIC50 (ie, the minimum inhibitory concentration of a drug 
required to inhibit the growth of 50% of organisms).
The antibiotic and anti-inflammatory drugs evaluated 
in the present study are listed in Table 1. The ophthalmic 
  solution preservatives tested in the present study were 
0.01% BAK (Wako Pure Chemical Industries, Osaka, 
Japan), 0.5% chlorobutanol (Wako), 1.0% polysorbate 
80 (Tween 20; ICN Biomedicals, Aurora, OH, USA), 
0.04% methyl   paraoxybenzoate (Wako), and 0.04% propyl 
  paraoxybenzoate (Wako). All preservatives were tested at 
commonly used concentrations.
Results
For all cell lines tested, cell viability after exposure to 
cefmenoxime was $80% (Figure 1). Cell viability after 
exposure of cells to the fluoroquinolones was concentra-
tion dependent, with $80% viability observed for solutions 
diluted 100-fold or more. Fluoroquinolones had less cell 
viability than the others except for tosufloxicin. Low toxicity 
was observed for betamethasone-containing drugs without 
BAK or polysorbate as the preservative (Figure 2). The cell 
viability of the other anti-inflammatory drugs was clearly 
concentration dependent. BAK-containing anti-inflammatory 
drugs had less cell viability than the drugs without BAK. 
Table 1 Antibiotic ophthalmic solutions evaluated in the present study
Active component Trade name Preservative CVS50*
Levofloxacin (0.5%) Cravit (Santen, Osaka, Japan) Quixin (in US;  
Vistakon, Jacksonville, FL, USA; with 0.005% BAK)
no 3
Moxifloxacin (0.5%) Vigamox (Alcon, Fort Worth, TX, USA) no 1
Gatifloxacin (0.3%) Gatiflo (Senju, Osaka, Japan) Zymar (in US;  
Allergan, Irvine, CA, USA; with 0.005% BAK)
no 2
Norfloxacin (0.3%) Noflo (Banyu, Tokyo, Japan) no 2
Tosufloxacin (0.3%) Tosuflo (Nitto, Nagoya, Japan) no 3
Dibekacin (0.5%) Panimycin (Meiji, Tokyo, Japan) no 3
Cefmenoxime (0.5%) Bestron (Kaken, Tokyo, Japan) 0.026% methyl paraoxybenzoate, 0.014%  
propyl paraoxybenzoate, boric acid
4
Notes: *number of cell lines with viability $50% in the presence of a 10-fold dilution of the drug.
Abbreviation: BAK, benzalkonium chloride.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Nonsteroidal anti-inflammatory drugs had less cell viability 
than fluoromethorone with same concentration of BAK.
Using CVS50 as an indicator of cytotoxicity, the order 
of cell viability after exposure to the antibiotic solutions 
was determined to be cefmenoxime $ tosufloxicin $ 
dibekacin $ levofloxacin $ norfloxacin = gatifloxacin = mox-
ifloxacin (Table 1), whereas that for the anti-inflammatory 
drugs  was  betamethasone  $  betamethasone  + 
  fradiomycin . preservative-free diclofenac $   preservative-free 
bromfenac .. 0.02% fluoromethorone $ 0.1% fluorometho-
rone = diclofenac +   preservative (Diclod) = bromfenac + pre-
servative (Bronuck) = pranoprofen (Table 2). The calculated 
CVS50 of the antibiotics ranged between one and four, 
whereas that of anti-inflammatory drugs preserved with BAK 
and Diclod was zero. These data are consistent with the results 
presented in Figures 1 and 2, which indicate that cell viability 
after exposure to antibiotics was generally higher than after 
exposure of cells to anti-inflammatory drugs.
Of the preservatives tested, BAK and polysorbate were 
cytotoxic to all cell lines (Figure 3). Propyl paraoxybenzoate 
exhibited cytotoxicity only in the SIRC and conjunctival cell 
lines, whereas chlorobutanol and methyl paraoxybenzoate 
did not exhibit any cytotoxic effects.
Discussion
The fluoroquinolones are broad-spectrum antibiotics that are 
the most commonly used drugs for the pre- and postoperative 
control of infection after eye surgery. In the present study, 
cefmenoxime, dibekacin, and tosufloxacin appeared to be 
the least cytotoxic. These results are partially consistent with 
those of a previous study performed in a single cell line11 and 
support previous reports that levofloxacin is less toxic than 
moxifloxacin12 or gatifloxacin.13 Many previous studies evalu-
ating the cytotoxicity of fluoroquinolones have used solutions 
preserved with BAK,14,15 which had a significant effect on 
the results. However, in the present study we were able to 
evaluate the toxicity of the pharmaceutical components of 
the ophthalmic solutions because we used preservative-free 
fluoroquinolone solutions. The results of the present study 
indicate that antibiotics are more toxic to conjunctival cells 
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Figure 1 Effects of antibiotic ophthalmic solutions on the viability of cultured rabbit corneal epithelial cells (RC-1 and SIRC), bovine corneal epithelial cells (BCE), and human 
conjunctival cells (Chang) after 48 h exposure. Data are the mean ± sD. Cefmenoxime was the least toxic. The cell viability score was determined and the order of cell viability 
was cefmenoxime $ tosufloxicin $ dibekacin $ levofloxacin $ norfloxacin = gatifloxacin = moxifloxacin (Table 1).Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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than to corneal cells, except for cefmenoxime, which was 
not cytotoxic against any of the cell lines used.
Dose-dependent cytotoxicity was observed for all 
  anti-inflammatory drugs preserved with BAK in all cell 
lines. The corneal toxicity of preservative-containing 
  solutions of diclofenac16–18 and bromfenac19 has already 
been documented and the present study further revealed that 
preservative-free diclofenac and bromfenac exhibit consider-
able toxicity. Pranoprofen preserved with BAK exhibited the 
greatest   toxicity, although this may be due to the fact that 
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Figure 2 Effects of anti-inflammatory ophthalmic solutions on the viability of cultured rabbit corneal epithelial cells (RC-1 and SIRC), bovine corneal epithelial cells (BCE), 
and human conjunctival cells (Chang) after 48 h exposure. Data are the mean ± SD. Data for benzalkonium chloride (BAK)-free drugs are indicated by the dotted lines. Cell 
viability was greater in all BAK-free solutions, except for Diclod, compared with solutions containing BAK. The cell viability score was determined and the order of viability 
was betamethasone $ betamethasone + fradiomycin . preservative-free diclofenac $ preservative-free bromfenac .. 0.02% fluoromethorone $ 0.1% fluoromethorone = 
diclofenac + preservative (Diclod) = bromfenac + preservative (Bronuck) = pranoprofen.
Table 2 Anti-inflammatory ophthalmic solutions evaluated in the present study
Active component Trade name Preservative CVS50*
Betamethasone (0.1%) Rinderon (Shinogi, Osaka, Japan) 0.05% methyl paraoxybenzoate, 0.02%  
propyl paraoxybenzoate
4
Betamethasone (0.1%) +  
fradiomycin (0.35%)
Rinderon A (Shionogi) same as rinderon 4
Fluoromethorone (0.1%) Flumethoron 0.1% (Santen, Osaka, Japan) 0.005% BAK, polysorbate 80, 0
Fluoromethorone (0.02%) Flumethoron 0.02% (Santen) 0.005% BAK, polysorbate 80 0
Diclofenac (0.1%) Diclod (Wakamoto, Tokyo, Japan) Voltaren  
Ophthalmic Solution (in US; Novartis, East  
Hanover, NJ, USA)
Chlorobutanol, polysorbate 80, boric acid 0
Preservative-free diclofenac No brand name (experimental use only) no 1
Bromfenac (0.1%) Bronuck (Senju, Osaka, Japan) Xibrom (in  
US; ISTA Pharmaceuticals, Irvine, CA, USA)
0.005% BAK, polysorbate 80 0
Preservative-free bromfenac No brand name (experimental use only) no 3
Pranoprofen (0.1%) Niflan (Senju) 0.007% BAK, polysorbate 80, boric acid 0
Notes: *number of cell lines with viability $50% in the presence of a 10-fold dilution of the drug.
Abbreviation: BAK, benzalkonium chloride.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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this   solution   contained the highest concentration of BAK. Of 
the actual preservatives evaluated in the present study, the 
cytotoxic effects of BAK, polysorbate,8 and cholorobutanol9 
were comparable to those reported previously; both methyl 
paraoxybenzoate and chlorobutanol exhibited significant 
cytotoxic effects at high concentrations.10
On the basis of the results of the present study, it is 
likely that any postoperative epithelial damage may be 
caused primarily by anti-inflammatory drugs because the 
cell   viability determined in the present study for the routinely 
used   nonsteroidal anti-inflammatory drugs (ie, Diclod and 
  Bronuck) were very low compared with values determined 
for the antibiotics. CVS50 was demonstrated to be a useful 
system for comparisons of the cytotoxicity of different oph-
thalmic solutions, as evidenced by comparable results for 
MTT assay using multiple cell lines and various drug concen-
trations. In addition, we calculated another number [(number 
of cell lines with viability .80%) – (number of cell lines with 
viability ,40%)] for each drug at a 10-fold   dilution based on 
the cell viability of different cell lines and the order of this 
number for tested solution was the same as that for CVS50. 
Considering biological fluctuations in   cellular   reaction to 
the drugs, we have to be careful of evaluation of the value 
of cell viability and the method for expressing general trend 
such as CVS50 may be one of the solutions.
The limitations of the present study include the use of 
bioassays only to evaluate cytotoxicity and the relatively long 
exposure time. However, the standardization of methods to 
evaluate the toxicity of ophthalmic solutions is still under 
development and the cytotoxic and/or ocular toxic effects 
of drugs clearly need to be evaluated more comprehensively. 
In the present study, we attempted to address these issues 
by evaluating the effects of a range of drug concentrations 
in four commercially available cell lines. We were able to 
compare the cytotoxic effects of the drugs easily using the 
CVS as well as graphically by plotting cell viability against 
drug concentration. With regard to exposure time, optimal 
exposure times for in vitro cell culture systems have not yet 
been established. It is common to use 48 h exposure followed 
by 48 h recovery in in vitro cytotoxicity assays; however, 
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Figure 3 Effects of preservatives on the viability of cultured rabbit corneal epithelial cells (RC-1 and SIRC), bovine corneal epithelial cells (BCE), and human conjunctival cells 
(Chang) after 48 h exposure. Data are the mean ± SD. Benzalkonium chloride and polysorbate were shown to have dose-dependent cytotoxic effects.Clinical Ophthalmology
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  epithelial cells proliferate rapidly and further studies in 
  epithelial cells are needed using shorter exposure times.
Conclusion
In conclusion, the toxicity of a wide range of BAK-free 
  ophthalmic solutions used postoperatively to control   infection 
and inflammation was evaluated in four ocular   surface cell 
lines. Because sufficient data regarding cell viability from 
multiple cell lines with different drug concentrations were 
available, the results of the MTT assay were expressed 
as CVS to enable the simple comparison of drug effects. 
The cytotoxicity of antibiotics was found to be dependent on 
the pharmaceutical components of the solution, whereas the 
  toxicity of anti-inflammatory drugs was found to be depen-
dent on both the pharmaceutical components of the solution 
and the preservative used. Based on the results of the present 
study, postoperative drug-induced epitheliopathy is most 
likely due to the effects of anti-inflammatory drugs.
Disclosure
The authors report no conflicts of interest in this work.
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